Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment

BJU International

Volumn 110, Issue 11 B, 2012, Pages

  Morgentaler, Abraham ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

CANCER GROWTH; CANCER PROGNOSIS; CANCER SIZE; DISEASE ASSOCIATION; GLEASON SCORE; HUMAN; NOTE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SEMINAL VESICLE; TESTOSTERONE BLOOD LEVEL; TUMOR INVASION; BLOOD; MALE; PATHOLOGY; PROSTATE; PROSTATE TUMOR;

HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; TESTOSTERONE;

EID: 84876422426     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11243.x     Document Type: Note

References (2)

1. Morgentaler A et al. Incidence of occult prostate cancer among men with low total or free serum testosterone. JAMA 1996; 276: 1904 - 6
2. Morgentaler A. Turning Conventional Wisdom Upside-Down: Low Serum Testosterone and High-Risk Prostate Cancer. Cancer 2011; 117: 3885-8